Researchers await verification of aspirin and cancer survival announcement A report that aspirin doubled the life expectancy of patients with gastrointestinal cancer should be viewed with caution until there is proof to substantiate the claim, said Australian oncologist and cancer researcher, Associate Professor Peter Gibbs. The European Cancer Congress in Vienna recently announced a Netherlands…
Details
The President of Golden Days FM, Melbourne’s Senior Broadcast radio, recently spoke to Professor Andrew Tonkin, a senior investigator to the ASPREE trial on the progress of the study. Prof. Tonkin, Head of the Cardiovascular Research Unit at Monash University, oversees cardiovascular aspects of ASPREE. Our thanks to Larry James for the opportunity to discuss the study with listeners…
Details
We are delighted to have Australian of the Year, Ita Buttrose, feature in two ASPREE Community Service Announcements (CSAs). The short 30 second and 15 second videos thank ASPREE participants for their extraordinary contribution to the health of future generations. Both CSAs are currently being aired on TVs across south eastern Australia. The radio CSA can be…
DetailsLeading US health authority releases aspirin recommendations to prevent cardiovascular disease and cancer in middle-aged The US Preventive Services Task Force (USPSTF) yesterday proposed that aspirin should be taken by more people to prevent cardiovascular disease (heart attack and stroke) as well as colon cancer – but only if you are aged between 50 and…
Details
Our latest ‘Tablet’ participant newsletter is now online. What’s in this issue? Launch of the new Monash Biorepository and what this means to the trial Find out which 10 medical clinics have the highest number of ASPREE participants See a handy reference map outlining the number of participants per region We answer two frequently asked questions: Why ASPREE is testing low-dose aspirin and when can participants can expect to see study results? Find…
Details
Representatives from Museum Victoria recently visited the new Monash University DEPM Biorepository to learn about the inner workings of the state-of-the-art long term storage facility. Dr Joanna Sumner (pictured), Manager of Genetic Resources at Museum Victoria took a hands-on approach, examining the tanks, storage racks and other design considerations with colleagues Christine Tipton, Business and…
Details
Professor John McNeil, Principal Investigator to ASPREE in Australia, heads the School of Public Health & Preventive Medicine (SPHPM), the second largest school within the Faculty of Medicine, Nursing and Health Sciences at Monash University. For those interested, the SPHPM 2014 Annual Report, which gives an overview of the enormous scope of research being undertaken at the school, including the…
Details
We are so fortunate to have a terrific Biobank research team with a yen for travel and good food. Led by Tom Gilbert, the team of ten has clocked up hundreds of hours flying or driving around south eastern Australia, to collect and process samples for the Healthy Ageing Biobank. In addition to their important research work,…
Details
This week, two important events happened to the ASPREE Healthy Ageing Biobank. Thanks to the generosity of ASPREE participants, the team ‘banked’ baseline blood and urine samples from the 12,220th participant! So far, of these, 3000 participants have provided an additional three year follow-up sample. Each sample is linked to a wealth of clinical health information collected…
DetailsA recent report that an individual’s genetic make-up could determine whether aspirin had a positive or negative effect on colorectal (bowel) cancer, is inconclusive said a leading cancer researcher and oncologist, Associate Professor Peter Gibbs. The paper, which was based on an analysis of 17,000 people from ten different studies, found that aspirin and NSAIDs…
Details© 2019 All Rights Reserved. • Monash University, Department of Epidemiology and Preventive Medicine | Disclaimer & Privacy